Fabio Stagno
Messina, 98125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
Malondialdehyde at the Crossroads of Oxidative Stress, Lipid Peroxidation, Ferroptosis, and Hematological Malignancies: A Narrative Review.
Journal: Biomedicines
Published: July 25, 2026
Sequential TKI Treatment in Patients With Chronic Phase Chronic Myeloid Leukemia Resistant to Frontline Nilotinib or Dasatinib Therapy. A Real-Life Survey From the Italian Campus CML Network.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 09, 2026
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.
Journal: British journal of haematology
Published: April 19, 2026
Proteome and miRNAs Expression in Medication-Related Osteonecrosis of the Jaw.
Journal: International journal of molecular sciences
Published: April 16, 2026
Microenvironmental Drivers of Bone Disease in Multiple Myeloma: Oxidative Stress, Sterile Inflammation, Autophagy-Lysosomal Remodeling, and the Iron-Lipid Peroxidation Axis.
Journal: Biomolecules
Published: April 01, 2026
Next-Generation Redox Mediators: Itaconate, Nitro-Fatty Acids, Reactive Sulfur Species and Succinate as Emerging Switches in Predictive Redox Medicine.
Journal: Antioxidants (Basel, Switzerland)
Published: March 09, 2026
Association of hypomethylating agents + venetoclax in the real-life treatment of Myeloproliferative Neoplasms in blastic phase.
Journal: Leukemia research
Published: March 06, 2026
Diabetic Patients With Newly Diagnosed Chronic Myeloid Leukemia: TKI Choice and Early Adverse Events. A Real-Life Survey Within the Italian Chronic Myeloid Leukemia Network.
Journal: European journal of haematology
Published: February 24, 2026
Age and gender effects on molecular responses in chronic myeloid leukemia patients by first-line treatment: an Italian CML network cohort study.
Journal: Annals of hematology
Published: January 31, 2026
Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.
Journal: Cells
Published: January 15, 2026
Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs.
Journal: Frontiers in pharmacology
Published: January 03, 2026
Last Updated: 09/26/2026